{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T13:30:30Z","timestamp":1793885430505,"version":"4.8.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002973","name":"Daiichi-Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Cardiology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ajpc.2026.101680","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T23:21:14Z","timestamp":1779751274000},"page":"101680","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Trends in heart failure-related mortality among breast cancer patients in the United States from 1999 to 2024"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2021-1660","authenticated-orcid":false,"given":"Vikash","family":"Jaiswal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danisha","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kriti","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fakhar","family":"Latif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusra Minahil","family":"Nasir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupam","family":"Halder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Banach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garima","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg C.","family":"Fonarow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Barac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpc.2026.101680_bib0001","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/cncr.34503","article-title":"Trends in breast cancer mortality by race\/ethnicity, age, and US census region, United States\u20141999-2020","volume":"129","author":"Ellington","year":"2023","journal-title":"Cancer"},{"key":"10.1016\/j.ajpc.2026.101680_bib0002","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1097\/EDE.0000000000001394","article-title":"Recent changes in the patterns of breast cancer as a proportion of all deaths according to race and ethnicity","volume":"32","author":"Trentham-Dietz","year":"2021","journal-title":"Epidemiol (Camb Mass)"},{"key":"10.1016\/j.ajpc.2026.101680_bib0003","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.cardfail.2009.04.011","article-title":"Trastuzumab-induced cardiomyopathy: not as benign as it looks? A retrospective study","volume":"15","author":"Guglin","year":"2009","journal-title":"J Card Fail"},{"key":"10.1016\/j.ajpc.2026.101680_bib0004","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.ijrobp.2015.11.040","article-title":"Cardiovascular disease risk in a large, population-based cohort of breast cancer survivors","volume":"94","author":"Boekel","year":"2016","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"key":"10.1016\/j.ajpc.2026.101680_bib0005","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.784409","article-title":"Long-term risk of death from heart disease among breast cancer patients","volume":"9","author":"Agha","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.ajpc.2026.101680_bib0006","unstructured":"Centers for Disease Control and Prevention, National Center for Health Statistics. Multiple Cause of Death Data on CDC WONDER [cited 2026 March 4]. Available from: https:\/\/wonder.cdc.gov\/mcd.html(open in a new window)."},{"key":"10.1016\/j.ajpc.2026.101680_bib0007","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ajpc.2026.101680_bib0008","first-page":"1","article-title":"NCHS urban-rural classification scheme for counties","author":"Ingram","year":"2012","journal-title":"Vital Health Stat 2 Data Eval Methods Res"},{"issue":"1\u201316","key":"10.1016\/j.ajpc.2026.101680_bib0009","first-page":"20","article-title":"Age standardization of death rates: implementation of the year 2000 standard. National vital statistics reports : from the","volume":"47","author":"Anderson","year":"1998","journal-title":"Cent Dis Control Prev Natl Cent Health Stat Natl Vital Stat Syst"},{"key":"10.1016\/j.ajpc.2026.101680_bib0010","series-title":"Joinpoint regression program","year":"2016"},{"key":"10.1016\/j.ajpc.2026.101680_bib0011","doi-asserted-by":"crossref","DOI":"10.15420\/cfr.2023.05","article-title":"Global public health burden of heart failure: an updated review","volume":"9","author":"Shahim","year":"2023","journal-title":"Card Fail Rev"},{"key":"10.1016\/j.ajpc.2026.101680_bib0012","first-page":"524","article-title":"Breast cancer statistics, 2022","volume":"72","author":"Giaquinto","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajpc.2026.101680_bib0013","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.0569","article-title":"Risk prediction models for cardiotoxicity of chemotherapy among patients with breast cancer: a systematic review","volume":"6","author":"Kabor\u00e9","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"Suppl 2","key":"10.1016\/j.ajpc.2026.101680_bib0014","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1016\/j.breast.2015.07.034","article-title":"Optimal adjuvant treatment for patients with HER2-positive breast cancer in 2015","volume":"24","author":"Zardavas","year":"2015","journal-title":"Breast"},{"key":"10.1016\/j.ajpc.2026.101680_bib0015","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0910383","article-title":"Adjuvant trastuzumab in HER2-positive breast cancer","volume":"365","author":"Slamon","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2026.101680_bib0016","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jaccao.2022.09.007","article-title":"Pharmacovigilance analysis of heart failure associated with anti-HER2 monotherapies and combination regimens for cancer","volume":"5","author":"Waliany","year":"2023","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.ajpc.2026.101680_bib0017","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa1703643","article-title":"Adjuvant Pertuzumab and Trastuzumab in early HER2-positive breast cancer","volume":"377","author":"von Minckwitz","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2026.101680_bib0018","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/CIRCULATIONAHA.119.044750","article-title":"Aromatase inhibitors and the risk of cardiovascular outcomes in women with breast cancer: a population-based cohort study","volume":"141","author":"Khosrow-Khavar","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2026.101680_bib0019","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00280-023-04506-x","article-title":"PARP inhibitor plus chemotherapy versus chemotherapy alone in patients with triple-negative breast cancer: a systematic review and meta-analysis based on randomized controlled trials","volume":"91","author":"Li","year":"2023","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.ajpc.2026.101680_bib0020","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/cvr\/cvz035","article-title":"Common risk factors for heart failure and cancer","volume":"115","author":"Meijers","year":"2019","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ajpc.2026.101680_bib0021","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11906-018-0812-z","article-title":"The global epidemic of the metabolic syndrome","volume":"20","author":"Saklayen","year":"2018","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.ajpc.2026.101680_bib0022","first-page":"34","article-title":"The relationship between body composition and left ventricular performance in women with breast, lymphoma, or sarcoma cancer","volume":"10","author":"Mabudian","year":"2024","journal-title":"Cardio-Oncol"},{"key":"10.1016\/j.ajpc.2026.101680_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.clbc.2019.04.012","article-title":"Personalized decision making in early stage breast cancer: applying clinical prediction models for anthracycline cardiotoxicity and breast cancer mortality demonstrates substantial heterogeneity of benefit-harm trade-off","volume":"19","author":"Upshaw","year":"2019","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.ajpc.2026.101680_bib0024","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1056\/NEJMsa1909301","article-title":"Projected U.S. State-level prevalence of adult obesity and severe obesity","volume":"381","author":"Ward","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2026.101680_bib0025","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/ejhf.2563","article-title":"Sex and central obesity in heart failure with preserved ejection fraction","volume":"24","author":"Sorimachi","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ajpc.2026.101680_bib0026","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.3390\/cancers16101845","article-title":"Risk prediction, diagnosis and management of a breast cancer patient with treatment-related cardiovascular toxicity: an essential overview","volume":"16","author":"Cronin","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ajpc.2026.101680_bib0027","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/heartjnl-2022-321859","article-title":"A narrative review of heart failure with preserved ejection fraction in breast cancer survivors","volume":"109","author":"Yogeswaran","year":"2023","journal-title":"Heart"},{"key":"10.1016\/j.ajpc.2026.101680_bib0028","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1001\/jama.2023.25881","article-title":"Analysis of breast cancer mortality in the US-1975 to 2019","volume":"331","author":"Caswell-Jin","year":"2024","journal-title":"JAMA"},{"issue":"Suppl 2","key":"10.1016\/j.ajpc.2026.101680_bib0029","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1016\/S0049-3848(10)70023-2","article-title":"The \u201ccommon soil hypothesis\u201d: evidence from population studies?","volume":"125","author":"Donati","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.ajpc.2026.101680_bib0030","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1016\/j.jacc.2019.02.042","article-title":"Disparities in cardiovascular mortality related to heart failure in the United States","volume":"73","author":"Glynn","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2026.101680_bib0031","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.cardfail.2023.07.006","article-title":"Heart failure epidemiology and outcomes statistics: a report of the heart failure society of America","volume":"29","author":"Bozkurt","year":"2023","journal-title":"J Card Fail"},{"key":"10.1016\/j.ajpc.2026.101680_bib0032","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jchf.2022.06.012","article-title":"Trends in heart failure-related mortality among older adults in the United States from 1999 to 2019","volume":"10","author":"Siddiqi","year":"2022","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.ajpc.2026.101680_bib0033","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13643-023-02382-3","article-title":"Geographic and sociodemographic access to systemic anticancer therapies for secondary breast cancer: a systematic review","volume":"13","author":"Pearson","year":"2024","journal-title":"Syst Rev"},{"key":"10.1016\/j.ajpc.2026.101680_bib0034","series-title":"Breast cancer metastasis and drug resistance.vol 1152. advances in experimental medicine and biology","first-page":"31","article-title":"Health and racial disparity in breast cancer","author":"Yedjou","year":"2019"},{"key":"10.1016\/j.ajpc.2026.101680_bib0035","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/HCO.0000000000000855","article-title":"Racial and ethnic disparities in heart failure: current state and future directions","volume":"36","author":"Lewsey","year":"2021","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.ajpc.2026.101680_bib0036","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1002\/ejhf.1920","volume":"22","author":"Lyon","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ajpc.2026.101680_bib0037","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001303","article-title":"Go AS. Incident atrial fibrillation and risk of death in adults with chronic kidney disease","volume":"3","author":"Bansal","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ajpc.2026.101680_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2024.102372","article-title":"The cardioprotective potential of sodium-glucose cotransporter 2-inhibitors in breast cancer therapy-related cardiac dysfunction - a systematic review","volume":"49","author":"Chong","year":"2024","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.ajpc.2026.101680_bib0039","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s10741-023-10328-z","article-title":"ACEI\/ARB and beta-blocker therapies for preventing cardiotoxicity of antineoplastic agents in breast cancer: a systematic review and meta-analysis","volume":"28","author":"Gao","year":"2023","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.ajpc.2026.101680_bib0040","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/ehjcvp\/pvad057","article-title":"Post-diagnostic statin use and its association with cancer recurrence and mortality in breast cancer patients: a systematic review and meta-analysis","volume":"9","author":"Jaiswal","year":"2023","journal-title":"Eur Heart J - Cardiovasc Pharmacother"}],"container-title":["American Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667726002552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667726002552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T12:47:32Z","timestamp":1793882852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666667726002552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":40,"alternative-id":["S2666667726002552"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpc.2026.101680","relation":{},"ISSN":["2666-6677"],"issn-type":[{"value":"2666-6677","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in heart failure-related mortality among breast cancer patients in the United States from 1999 to 2024","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpc.2026.101680","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101680"}}